Chlamydophila pneumoniae in chronic rhinosinusitis

References

• Kaliner MA. Recurrent sinusitis: examining medical treatment options. Am J Rhinol 1997; 11: 123–32
   PubMedGoogle Scholar
• Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003; 129(3 Suppl)S1–S32
   PubMed Web of Science ®Google Scholar
• Duncavage J. Chronic rhinosinusitis is not always infectious sinusitis. Curr Opin Otolaryngol Head Neck Surg 2005; 13: 1
   Google Scholar
• Kostamo K, Richardson M, Virolainen-Julkunen A, Leivo I, Malmberg H, Ylikoski J, et al. Microbiology of chronic hyperplastic sinusitis. Rhinology 2004; 42: 213–18
   PubMedGoogle Scholar
• Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8: 451–61
   PubMed Web of Science ®Google Scholar
• Grayston JT. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 2000; 181(Suppl 3)S402–S410
   PubMed Web of Science ®Google Scholar
• Hyman CL, Roblin PM, Gaydos CA, Quinn TC, Schachter J, Hammerschlag MR. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 1995; 20: 1174–8
   PubMed Web of Science ®Google Scholar
• Melby KK, Kvien TK, Glennas A, Anestad G. Chlamydia pneumoniae as a trigger of reactive arthritis. Scand J Infect Dis 1999; 31: 327–8
   PubMedGoogle Scholar
• Gencay M, Rudiger JJ, Tamm M, Soler M, Perruchoud AP, Roth M. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med 2001; 163: 1097–100
   PubMed Web of Science ®Google Scholar
• Leinonen M, Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2002; 2: 11–17
   PubMed Web of Science ®Google Scholar
• Campbell LA, Kuo CC. Chlamydia pneumoniae – an infectious risk factor for atherosclerosis?. Nat Rev Microbiol 2004; 2: 23–32
   PubMed Web of Science ®Google Scholar
• Belland RJ, Ouellette SP, Gieffers J, Byrne GI. Chlamydia pneumoniae and atherosclerosis. Cell Microbiol 2004; 6: 117–27
   PubMedGoogle Scholar
• Tong CYW, Sillis M. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol 1993; 46: 313–17
   PubMed Web of Science ®Google Scholar
• Kuoppa Y, Boman J, Scott L, Kumlin U, Eriksson I, Allard A. Quantitative detection of respiratory Chlamydia pneumoniae infection by real-time PCR. J Clin Microbiol 2002; 40: 2273–4
   PubMedGoogle Scholar
• Valimaa L, Sjoroos M, Luhtala M, Toivanen P, Lovgren T, Ilonen J. Detection of HLA-B27 alleles by group-specific amplification and time-resolved fluorometry. J Immunol Methods 1998; 219: 131–7
   PubMedGoogle Scholar
• Nystrom-Rosander C, Thelin S, Hjelm E, Lindquist O, Pahlson C, Friman G. High incidence of Chlamydia pneumoniae in sclerotic heart valves of patients undergoing aortic valve replacement. Scand J Infect Dis 1997; 29: 361–5
   PubMed Web of Science ®Google Scholar
• Falck G, Engstrand I, Gad A, Gnarpe J, Gnarpe H, Laurila A. Demonstration of Chlamydia pneumoniae in patients with chronic pharyngitis. Scand J Infect Dis 1997; 29: 585–9
   PubMed Web of Science ®Google Scholar
• Falck G, Gnarpe J, Gnarpe H. Persistent Chlamydia pneumoniae infection in a Swedish family. Scand J Infect Dis 1996; 28: 271–3
   PubMed Web of Science ®Google Scholar
• Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74: 877–84
   PubMed Web of Science ®Google Scholar
• Cultrara A, Goldstein NA, Ovchinsky A, Reznik T, Roblin PM, Hammerschlag MR. The role of Chlamydia pneumoniae infection in children with chronic sinusitis. Arch Otolaryngol Head Neck Surg 2003; 129: 1094–7
   PubMedGoogle Scholar
• MacLeod CM, Hamid QA, Cameron L, Tremblay C, Brisco W. Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa. Adv Ther 2001; 18: 75–82
   PubMed Web of Science ®Google Scholar
• Lee RE, Kaza S, Plano GV, Casiano RR. The role of atypical bacteria in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2005; 133: 407–10
   PubMedGoogle Scholar
• Hashiguchi K, Ogawa H, Kazuyama Y. Seroprevalence of Chlamydia pneumoniae infections in otolaryngeal diseases. J Laryngol Otol 1992; 106: 208–10
   PubMedGoogle Scholar
• Hashigucci K, Ogawa H, Suzuki T, Kazuyama Y. Isolation of Chlamydia pneumoniae from the maxillary sinus of a patient with purulent sinusitis. Clin Infect Dis 1992; 15: 570–1
   PubMedGoogle Scholar
• Cochrane M, Pospischil A, Walker P, Gibbs H, Timms P. Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures. J Clin Microbiol 2003; 41: 1454–7
   PubMed Web of Science ®Google Scholar
• Hjelm E, Wesslen L, Gnarpe H, Gnarpe J, Nystrom-Rosander C, Rolf C, et al. Antibodies to Chlamydia pneumoniae in young Swedish orienteers. Scand J Infect Dis 2001; 33: 589–92
   PubMedGoogle Scholar
• Ngeh J, Anand V, Gupta S. Chlamydia pneumoniae and atherosclerosis – what we know and what we don't. Clin Microbiol Infect 2002; 8: 2–13
   PubMed Web of Science ®Google Scholar